59 studies found for:    NIAID | Open Studies | Exclude Unknown | healthy
Show Display Options
Rank Status Study
21 Recruiting Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
Conditions: Prevention of Zika Infection;   Zika-Specific Immune Response
Intervention: Biological: VRC-ZKADNA085-00-VP
22 Recruiting Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: Prevention of HIV Infection;   HIV Antibodies;   Monoclonal Antibody, Human;   Neutralizing Antibody
Intervention: Biological: VRC-HIVMAB080-00-AB
23 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
24 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Health
Intervention:
25 Recruiting Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Conditions: Healthy;   Rheumatoid Arthritis Prevention
Interventions: Drug: Hydroxychloroquine;   Drug: HCQ Placebo
26 Recruiting Tissue Biopsy and Imaging Studies in HIV-Infected Patients
Conditions: HIV;   Healthy Volunteers
Intervention:
27 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
28 Recruiting Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
Conditions: Microbiome;   Antibiotic-Induced VVC;   Vaginal Candidiasis
Intervention:
29 Recruiting Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
Condition: Influenza
Intervention: Biological: Trivalent inactivated influenza vaccine
30 Recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pneumococcal Infection;   Pneumonia;   Pathogen Resistance
Intervention: Drug: Colistimethate sodium
31 Recruiting Phase 1 Study of dmLT ID Vaccination in Healthy Adults
Condition: Gastroenteritis Escherichia Coli
Interventions: Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
32 Not yet recruiting PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
Condition: Plasmodium Falciparum Infection
Interventions: Biological: PfSPZ;   Other: Placebo;   Drug: Chloroquine
33 Not yet recruiting H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
Conditions: Avian Influenza;   Influenza
Interventions: Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine
34 Recruiting A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults
Condition: Schistosomiasis
Interventions: Biological: Sm-TSP-2/Alhydrogel;   Biological: Sm-TSP-2/Alhydrogel/GLA-AF;   Other: Placebo
35 Not yet recruiting Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: VRC01LS
36 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
37 Not yet recruiting Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Condition: Dengue
Interventions: Biological: TV005 vaccine;   Biological: Placebo
38 Not yet recruiting A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow Fever
Interventions: Biological: YF Vax 17D Strain;   Drug: ISA-720;   Biological: MVA-BN Yellow Fever Vaccine;   Other: Placebo;   Biological: MVA Smallpox Vaccine
39 Recruiting Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX®-GP HIV-1 DNA vaccine;   Biological: Interleukin-12 (IL-12) DNA adjuvant;   Biological: Placebo
40 Recruiting Analysis of Lyme Disease Lesions
Conditions: Erythema Migrans Lesions;   Erythema Migrans
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Indicates status has not been verified in more than two years